Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer.

Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, Miklavcic D.

Cancer Immunol Immunother. 2015 Jun 12. [Epub ahead of print]

PMID:
26067277
2.

Endoglin (CD105) Silencing Mediated by shRNA Under the Control of Endothelin-1 Promoter for Targeted Gene Therapy of Melanoma.

Tesic N, Kamensek U, Sersa G, Kranjc S, Stimac M, Lampreht U, Preat V, Vandermeulen G, Butinar M, Turk B, Cemazar M.

Mol Ther Nucleic Acids. 2015 May 5;4:e239. doi: 10.1038/mtna.2015.12.

PMID:
25942402
3.

Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects.

Stimac M, Dolinsek T, Lampreht U, Cemazar M, Sersa G.

PLoS One. 2015 Apr 24;10(4):e0124913. doi: 10.1371/journal.pone.0124913. eCollection 2015.

4.

Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity.

Mirković B, Markelc B, Butinar M, Mitrović A, Sosič I, Gobec S, Vasiljeva O, Turk B, Čemažar M, Serša G, Kos J.

Oncotarget. 2015 Aug 7;6(22):19027-42.

5.

Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.

Lampreht U, Kamensek U, Stimac M, Sersa G, Tozon N, Bosnjak M, Brozic A, de Sá Oliveira GG, Nakagawa T, Saeki K, Cemazar M.

J Membr Biol. 2015 Apr 4. [Epub ahead of print]

PMID:
25840833
6.

Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.

Kos S, Tesic N, Kamensek U, Blagus T, Cemazar M, Kranjc S, Lavrencak J, Sersa G.

J Membr Biol. 2015 Apr 4. [Epub ahead of print]

PMID:
25840832
7.

Adjuvant TNF-α therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness.

Cemazar M, Todorovic V, Scancar J, Lampreht U, Stimac M, Kamensek U, Kranjc S, Coer A, Sersa G.

Radiol Oncol. 2015 Mar 3;49(1):32-40. doi: 10.1515/raon-2015-0005. eCollection 2015 Mar.

8.

Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma.

Bosnjak M, Dolinsek T, Cemazar M, Kranjc S, Blagus T, Markelc B, Stimac M, Zavrsnik J, Kamensek U, Heller L, Bouquet C, Turk B, Sersa G.

Gene Ther. 2015 Jul;22(7):578-90. doi: 10.1038/gt.2015.26. Epub 2015 Apr 9.

PMID:
25781650
9.

Endoglin silencing has significant antitumor effect on murine mammary adenocarcinoma mediated by vascular targeted effect.

Dolinsek T, Markelc B, Bosnjak M, Blagus T, Prosen L, Kranjc S, Stimac M, Lampreht U, Sersa G, Cemazar M.

Curr Gene Ther. 2015;15(3):228-44.

PMID:
25619888
10.

Mcam Silencing With RNA Interference Using Magnetofection has Antitumor Effect in Murine Melanoma.

Prosen L, Markelc B, Dolinsek T, Music B, Cemazar M, Sersa G.

Mol Ther Nucleic Acids. 2014 Oct 28;3:e205. doi: 10.1038/mtna.2014.56.

11.

Inhibitor of endocytosis impairs gene electrotransfer to mouse muscle in vivo.

Markelc B, Skvarca E, Dolinsek T, Kloboves VP, Coer A, Sersa G, Cemazar M.

Bioelectrochemistry. 2015 Jun;103:111-9. doi: 10.1016/j.bioelechem.2014.08.020. Epub 2014 Aug 29.

PMID:
25200990
12.

Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases.

Campana LG, Mali B, Sersa G, Valpione S, Giorgi CA, Strojan P, Miklavcic D, Rossi CR.

Br J Oral Maxillofac Surg. 2014 Dec;52(10):957-64. doi: 10.1016/j.bjoms.2014.08.004. Epub 2014 Sep 1.

PMID:
25183266
13.

Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.

Hudej R, Miklavcic D, Cemazar M, Todorovic V, Sersa G, Bergamo A, Sava G, Martincic A, Scancar J, Keppler BK, Turel I.

J Membr Biol. 2014 Dec;247(12):1239-51. doi: 10.1007/s00232-014-9696-2. Epub 2014 Jun 24.

PMID:
24957014
14.

Electroporation-based technologies for medicine: principles, applications, and challenges.

Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D.

Annu Rev Biomed Eng. 2014 Jul 11;16:295-320. doi: 10.1146/annurev-bioeng-071813-104622. Epub 2014 May 27. Review.

PMID:
24905876
15.

A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents.

Blagus T, Zager V, Cemazar M, Sersa G, Kamensek U, Zegura B, Nunic J, Filipic M.

Biosens Bioelectron. 2014 Nov 15;61:102-11. doi: 10.1016/j.bios.2014.05.002. Epub 2014 May 10.

PMID:
24861570
16.

Intraoperative electrochemotherapy of colorectal liver metastases.

Edhemovic I, Brecelj E, Gasljevic G, Marolt Music M, Gorjup V, Mali B, Jarm T, Kos B, Pavliha D, Grcar Kuzmanov B, Cemazar M, Snoj M, Miklavcic D, Gadzijev EM, Sersa G.

J Surg Oncol. 2014 Sep;110(3):320-7. doi: 10.1002/jso.23625. Epub 2014 Apr 30.

17.

Electrochemotherapy: from the drawing board into medical practice.

Miklavčič D, Mali B, Kos B, Heller R, Serša G.

Biomed Eng Online. 2014 Mar 12;13(1):29. doi: 10.1186/1475-925X-13-29. Review.

18.

Schedule-dependent interaction between vinblastine and irradiation in experimental sarcoma.

Cemazar M, Dolinsek T, Kosjek T, Markelc B, Sersa G, Kloboves V, Strojan P.

Strahlenther Onkol. 2014 Jul;190(7):661-6. doi: 10.1007/s00066-014-0645-x. Epub 2014 Mar 11.

PMID:
24615190
19.

Changing electrode orientation, but not pulse polarity, increases the efficacy of gene electrotransfer to tumors in vivo.

Todorovic V, Kamensek U, Sersa G, Cemazar M.

Bioelectrochemistry. 2014 Dec;100:119-27. doi: 10.1016/j.bioelechem.2013.12.002. Epub 2013 Dec 18.

PMID:
24411306
20.

Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model.

Kamensek U, Sersa G, Cemazar M.

Mol Cancer. 2013 Nov 12;12(1):136. doi: 10.1186/1476-4598-12-136.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk